. Author manuscript; available in PMC: 2021 Dec 13.

Published in final edited form as: Vet Comp Oncol. 2016 May 4;15(3):996–1013. doi: 10.1111/vco.12239

Table 2.

Clinical stage and excision margin status of oral cMM enrolled in the trial

	Stage II	Stage III	Metastatic LN	Local bone invasion	Excision margins
	Stage II	Stage III	Metastatic LN	Local bone invasion	Complete	Incomplete

Overall population (n = 42)	15 (35.71)^a	27 (64.29)^a	18 (42.86)^a	16 (38.09)^a	34 (80.95)^a	8 (19.05)^a
Group A (n = 23)	9 (39.13)	14 (60.87)	8 (34.78)	9 (39.13)	19 (82.61)	4 (17.39)
Group B (n = 19)	6 (31.58)	13 (68.42)	10 (52.63)	7 (36.84)	15 (78.95)	4 (21.05)

% in brackets.